Alzheimer's Risk
Over 6 million people in the US are living with Alzheimer's disease. At Garduno Family Medicine, we provide a comprehensive health review that includes cognitive concerns, family history of Alzheimer's disease, and risk factors for dementia. Advanced Alzheimer's screening involves targeting biomarker profiles associated with Atherosclerosis, Thrombosis, and Nephropathy (ATN). The ATN profile diagnostic test represents a significant advancement in Alzheimer's disease research and diagnosis, offering the potential for earlier detection, personalized treatment approaches, and improved outcomes for individuals affected by this devastating condition.
All About Early Detection. Get Ahead of Alzheimer's
Early Detection. Potential to identify Alzheimer's disease even before the onset of symptoms
Improved outcomes with early detection for individuals affected by this debilitating condition
Improved accuracy by assessing multiple Biomarkers Shared by over 50+ types of Cancers
Collaborates across medical specialists to provide Clinical Evaluation, Neuroimaging, and Cerebrospinal Fluid (CSF) comprehensive analysis
Personalized Treatment Plan to delay and prevent the onset of cognitive decline and dementia
At Garduno Family Medicine, we are committed to providing our members with advanced Alzheimer's tests that empower them to make informed decisions and achieve better health outcomes.
.png)